Studies on the Inhibitor of Tumor Angiogenesis
博士 === 國立陽明大學 === 生物藥學研究所 === 96 === Thalidomide is an old drug with a wide variety of molecular mechanisms. Many clinical data showed that thalidomide has anti-angiogenic activity and the responder showed a significant decrease of serum bFGF level after treatment. Since bFGF is an important factor...
Main Authors: | Szu-Chieh Mei, 梅思潔 |
---|---|
Other Authors: | Rong-Tsun Wu |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/su525s |
Similar Items
-
The studies on the inhibitor of tumor angiogenesis
by: Ja-Wen Young, et al.
Published: (2003) -
The studies on the platform establishment for tumor angiogenesis inhibitors
by: Lei-Fang Tsai, et al.
Published: (2006) -
INHIBITORS OF ANGIOGENESIS IN BRAIN TUMORS – REVIEW
by: Mindov I., et al.
Published: (2019-02-01) -
The Inhibition of Tumor Growth and Microvascular Angiogenesis by the Potent Angiogenesis inhibitor, TNP-470 in Rats
by: Niwano, Mototaka
Published: (2012) -
The effect of deactivation or silencing of tumor stroma with angiogenesis inhibitor on malignancy of tumor metastases
by: Tachijian, Nataly
Published: (2021)